RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 118 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $130,123,836 | +39.0% | 5,676,067 | 0.0% | 2.56% | +45.0% |
Q2 2023 | $93,598,345 | -4.9% | 5,676,067 | +2.9% | 1.77% | -20.7% |
Q1 2023 | $98,406,635 | -38.7% | 5,516,067 | 0.0% | 2.23% | -31.6% |
Q4 2022 | $160,627,871 | +19.8% | 5,516,067 | +0.8% | 3.26% | +13.9% |
Q3 2022 | $134,041,000 | +563.1% | 5,471,067 | +12.3% | 2.86% | +430.6% |
Q2 2022 | $20,215,000 | -64.0% | 4,871,067 | 0.0% | 0.54% | -56.0% |
Q1 2022 | $56,115,000 | +15.4% | 4,871,067 | 0.0% | 1.22% | +42.8% |
Q4 2021 | $48,613,000 | -23.6% | 4,871,067 | 0.0% | 0.86% | -2.8% |
Q3 2021 | $63,616,000 | -10.5% | 4,871,067 | 0.0% | 0.88% | -22.7% |
Q2 2021 | $71,077,000 | -31.4% | 4,871,067 | 0.0% | 1.14% | -27.0% |
Q1 2021 | $103,608,000 | -16.6% | 4,871,067 | +16.6% | 1.56% | -10.1% |
Q4 2020 | $124,244,000 | +11.5% | 4,179,067 | -18.7% | 1.74% | -14.7% |
Q3 2020 | $111,393,000 | -4.1% | 5,140,408 | -1.3% | 2.04% | -10.0% |
Q2 2020 | $116,185,000 | +40.8% | 5,210,088 | -3.9% | 2.26% | -13.2% |
Q1 2020 | $82,528,000 | -33.7% | 5,422,312 | 0.0% | 2.61% | -30.9% |
Q4 2019 | $124,496,000 | +68.5% | 5,422,312 | +58.4% | 3.78% | -14.2% |
Q3 2019 | $73,888,000 | +78.2% | 3,422,312 | +81.6% | 4.40% | +97.8% |
Q2 2019 | $41,465,000 | -19.7% | 1,884,782 | 0.0% | 2.23% | -0.1% |
Q1 2019 | $51,662,000 | -1.5% | 1,884,782 | -3.4% | 2.23% | -27.0% |
Q4 2018 | $52,425,000 | -7.9% | 1,950,332 | 0.0% | 3.05% | +0.4% |
Q3 2018 | $56,891,000 | +18.0% | 1,950,332 | +26.5% | 3.04% | -2.8% |
Q2 2018 | $48,195,000 | – | 1,541,743 | – | 3.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |